John Woodson Rollins
CIK: 0002112941
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AIDX
20/20 Biolabs, Inc.
Director
Discretionary Trading P&L
Holdings
About Rollins John Woodson
Rollins John Woodson (SEC CIK 0002112941) files insider reports with the SEC as Director of 20/20 Biolabs, Inc. (AIDX).
Signal8 holds 2 ownership filings by Rollins John Woodson (1 Form 3, 1 Form 4), filed on Feb 23, 2026. Those filings report 2 transactions, the latest on Feb 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Rollins John Woodson's filings is in GAITHERSBURG, MD.
Recent filings by Rollins John Woodson
- Feb 19, 2026: Conversions of AIDX shares (2 lines, Form 4, code C).
Other insiders filing for 20/20 Biolabs, Inc. (AIDX)
- Bergman Alan B., Chief Financial Officer
- Zhou Jiming, Chief Operating Officer
- Cohen Jonathan M, Chief Executive Officer
- Ross Michael A., Director
- Compton John G., Director
- COHEN RICHARD M, Director